Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Studie Zur Neoadjuvanten Trimodalen Hyperthermen Radiochemotherapie Des Tief Sitzenden Rektumskarzinoms im Stadium UICC II + III

NCT03428867 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03428867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03428867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Studie Zur Neoadjuvanten Trimodalen Hyperthermen Radiochemotherapie Des Tief Sitzenden Rektumskarzinoms im Stadium UICC II + III
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
July 31, 2017
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

feasibilitystudy